Salvador
Martín Algarra
Consultor Médico
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (8)
2020
-
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors
Science Translational Medicine, Vol. 12, Núm. 565
2016
-
GRAY-B: An open label multicenter phase-2 GEM study on ipilimumab and radiation in patients with melanoma and brain metastases
Annals of Oncology, Vol. 27, pp. vi383
-
Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience
Clinical and Translational Oncology, Vol. 18, Núm. 11, pp. 1147-1157
2014
-
Guidelines for biomarker testing in metastatic melanoma: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 16, Núm. 4, pp. 362-373
-
Melanoma: Diagnosis, Staging, and Treatment. Consensus group recommendations
Advances in Therapy, Vol. 31, Núm. 9, pp. 945-960
-
Recomendaciones para la determinación de biomarcadores en el melanoma metastásico. Consenso Nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica
Revista Espanola de Patologia
2009
-
Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma
European Journal of Cancer, Vol. 45, Núm. 5, pp. 732-735
2005
-
Clinical practice guidelines on antiemetics in oncology
Expert Review of Anticancer Therapy, Vol. 5, Núm. 6, pp. 963-972